This article is more than 5 years old. Information may no longer be current.
ASH Annual Meeting and Exposition highlights developments in benign, malignant hematology
Click Here to Manage Email Alerts
ORLANDO, Fla. — The HemOnc Today and Healio.com/HemOnc team will present comprehensive live coverage from the ASH Annual Meeting and Exposition starting Dec. 5.
The meeting — expected to attract more than 20,000 hematology professionals — will feature the latest clinical, basic and translational research related to malignant and benign blood disorders.
The program will include a plenary session on Dec. 6 and a late-breaking abstract session on Dec. 8. Hundreds of other oral and poster abstracts scheduled for presentation during the 4-day meeting will explore all aspects of care, including prevention, diagnosis and treatment.
The conference also will include scientific forums and education sessions.
Content from HemOnc Today and Healio.com/HemOnc will include traditional articles and video commentaries.
We also will provide perspectives from experts who put study results in context and offer insights into how findings will affect patient care.
Our team will be onsite in Orlando throughout the meeting, so come back to Healio.com/HemOnc frequently for updates.